Express Scripts staking out million-dollar gene therapies
(Reuters) – Express Scripts Holding Co (ESRX.O) built a multi-billion enterprise pressuring drug companies to lower their prices for U.S. patients. Now it is quietly building a side business: getting paid to help drug companies dispense a new generation of high-priced drugs. FILE PHOTO: Express Scripts Chief Medical Officer Steve Miller poses for a portrait… Read More »